로딩 중…
지수 로딩 중…
aTyr Pharma, Inc.
ATYR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$0.45-2.68%
2026-06-18
Price Chart
aTyr Pharma, Inc.-91.29%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $44M |
| Revenue | $190000.00 |
| Net Income | $-70M |
| Total Assets | $80M |
| Net Assets | $58M |
| Value | |
| P/B | 0.76x |
| P/S | 232.48x |
| FCF Yield | -134.24% |
| Profitability | |
| ROE | -120.88% |
| ROA | -87.92% |
| Op. Margin | -38573.68% |
| Revenue Growth | -19.15% |
| Financial Health | |
| Debt Ratio | 37.82% |
| Total Debt | $12M |
| FCF | $-59M |
| Cash | $10M |
| Current Ratio | 5.78x |
| Performance | |
| 1Y Return | -91.29% |
| 1M Return | -6.73% |
| From 52W High | -93.82% |
| 1Y MDD | -94.01% |
| Trading | |
| Volume | 1,323,977 shares |
| Trading Value | $611452.00 |
| Per Share | |
| EPS | $-0.76 |
| BPS | $0.69 |